Market Research Logo

Israel Pharmaceuticals & Healthcare Q3 2019

Israel Pharmaceuticals & Healthcare Q3 2019

Key View:

Israel's current economic and political hurdles are doing little to further the long-term, systemic issues of anoverburdened health system, as reflected by an increasing frequency of severe outbreaks of flu and communicable. However, theaddition of 107 medical technologies to the state-subsidised health basket for 2019, a well as a sharp increase in investment forIsraeli digital health projects is gradually improving prospects for significant savings for the health budget and increasing the overallefficiency of the healthcare sector.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Dexcel Pharma
Neopharm Group
Perrigo (Agis Industries)
Taro Pharmaceutical Industries
Teva Pharmaceutical Industries
Israel Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report